In a recent paper, it has been reported that transgenic mice expressing other oncogenic versions of VAV1 can develop GATA3+ PTCL-not otherwise specified–like (PTCL-NOS) tumors in the presence of Trp53 deletion [37]. The gene discussed is VAV1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.